PJP ETF Profile

Family:	Invesco
Name:	Invesco Pharmaceuticals ETF

Inception Date:	23-Jun-2005
Termination Date:
Investment Objective:	The Invesco Pharmaceuticals ETF (Fund) is based on the Dynamic Pharmaceutical Intellidex Index (Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Index is comprised of common stocks of 30 US pharmaceuticals companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

Prospectus

Number of Holdings:	32
Shares Outstanding:	3,010,000
Total Net Assets:	233,869,200
NAV:	77.74
Net Expense Ratio:	0.56%

Asset Class:	Equities (Stocks)
Developed or Emerging:	Developed Market Funds
Country:	US
Region:
Strategy:	NYSE Intellidex proprietary model
Currency:
Commodity:
Sector:	Healthcare
Industry:	Pharmaceuticals
Dividend Type:
Tax Exempt State:
Maturity Duration:
Market Cap:	Broad Market / Multi-Cap
Credit Quality:
Mortgage Bond Types:
Bond Type:
Gov't Bond Types:
Reit Type:
Leverage Direction/Factor:
Is Currency Hedged:	No
US or Ex-US:	Domestic